Liver Fat
25
6
6
16
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 25 trials
100.0%
+13.5% vs benchmark
4%
1 trials in Phase 3/4
13%
2 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (25)
Fully Automated High-Throughput Quantitative MRI of the Liver
Intermittent Fasting for NAFLD in Adults
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
Effect of Lifestyle Intervention on Mobilization of Fat Storage and Iron Deposition in Obesity
Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
Treating Pediatric NAFLD with Nutrition
Liver, Diet and Genetic Background
Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue
The Visceral Adiposity Measurement and Observation Study
Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification
Diet, Immunometabolism and Non-alcoholic Fatty Liver Disease
Short-term Fat Overfeeding on the Effects of Liver Metabolism
Extreme Exercise and Energy Expenditure (4E) Study
Habitual Diet and Avocado Trial
Effect of Lyophilized Cornus Mas L. on Anthropometric and Biochemical Parameters in Metabolic Associated Fatty Liver Disease Patients
Low-calorie Diet and Body Composition Prior to Roux-en-Y Gastric Bypass
MR Fat Quantification and Elastography During a Very Low-calorie-ketogenic Diet (Pronokal Method®) vs a Low Calorie Diet
Role of Liver and Visceral Fat in Glucose and Lipid Metabolism During Pregnancy